Cargando…

Antimicrobial Peptides

The rapid increase in drug-resistant infections has presented a serious challenge to antimicrobial therapies. The failure of the most potent antibiotics to kill “superbugs” emphasizes the urgent need to develop other control agents. Here we review the history and new development of antimicrobial pep...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahar, Ali Adem, Ren, Dacheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873676/
https://www.ncbi.nlm.nih.gov/pubmed/24287494
http://dx.doi.org/10.3390/ph6121543
_version_ 1782297136778444800
author Bahar, Ali Adem
Ren, Dacheng
author_facet Bahar, Ali Adem
Ren, Dacheng
author_sort Bahar, Ali Adem
collection PubMed
description The rapid increase in drug-resistant infections has presented a serious challenge to antimicrobial therapies. The failure of the most potent antibiotics to kill “superbugs” emphasizes the urgent need to develop other control agents. Here we review the history and new development of antimicrobial peptides (AMPs), a growing class of natural and synthetic peptides with a wide spectrum of targets including viruses, bacteria, fungi, and parasites. We summarize the major types of AMPs, their modes of action, and the common mechanisms of AMP resistance. In addition, we discuss the principles for designing effective AMPs and the potential of using AMPs to control biofilms (multicellular structures of bacteria embedded in extracellular matrixes) and persister cells (dormant phenotypic variants of bacterial cells that are highly tolerant to antibiotics).
format Online
Article
Text
id pubmed-3873676
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-38736762014-01-06 Antimicrobial Peptides Bahar, Ali Adem Ren, Dacheng Pharmaceuticals (Basel) Review The rapid increase in drug-resistant infections has presented a serious challenge to antimicrobial therapies. The failure of the most potent antibiotics to kill “superbugs” emphasizes the urgent need to develop other control agents. Here we review the history and new development of antimicrobial peptides (AMPs), a growing class of natural and synthetic peptides with a wide spectrum of targets including viruses, bacteria, fungi, and parasites. We summarize the major types of AMPs, their modes of action, and the common mechanisms of AMP resistance. In addition, we discuss the principles for designing effective AMPs and the potential of using AMPs to control biofilms (multicellular structures of bacteria embedded in extracellular matrixes) and persister cells (dormant phenotypic variants of bacterial cells that are highly tolerant to antibiotics). MDPI 2013-11-28 /pmc/articles/PMC3873676/ /pubmed/24287494 http://dx.doi.org/10.3390/ph6121543 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Bahar, Ali Adem
Ren, Dacheng
Antimicrobial Peptides
title Antimicrobial Peptides
title_full Antimicrobial Peptides
title_fullStr Antimicrobial Peptides
title_full_unstemmed Antimicrobial Peptides
title_short Antimicrobial Peptides
title_sort antimicrobial peptides
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873676/
https://www.ncbi.nlm.nih.gov/pubmed/24287494
http://dx.doi.org/10.3390/ph6121543
work_keys_str_mv AT baharaliadem antimicrobialpeptides
AT rendacheng antimicrobialpeptides